Cargando…

Prognostic Value of Plasma Long Noncoding RNA ANRIL for In-Stent Restenosis

BACKGROUND: In-stent restenosis (ISR) remains a major cause of failure of contemporary percutaneous revascularization therapies. Invasive biomarkers to improve the prognosis of ISR should be considered. This study aimed to investigate the association between plasma ANRIL expression and ISR. MATERIAL...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Fang, Su, Xi, Liu, Chengwei, Wu, Mingxiang, Li, Bei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	International Scientific Literature, Inc. 2017
Materias:	Clinical Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5635947/ https://www.ncbi.nlm.nih.gov/pubmed/28970468 http://dx.doi.org/10.12659/MSM.904352

Ejemplares similares

Predictive value of using plasma long non-coding RNAs ANRIL and HOXA11-AS for in-stent restenosis
por: Jin, Zhijiang, et al.
Publicado: (2022)

An increase in a long noncoding RNA ANRIL in peripheral plasma is an indicator of stable angina
por: Jiao, Yunjuan, et al.
Publicado: (2023)

Prognostic value of plasma phenylalanine and gut microbiota-derived metabolite phenylacetylglutamine in coronary in-stent restenosis
por: Fu, Yuan, et al.
Publicado: (2022)

Association between Long Noncoding RNA ANRIL Expression Variants and Susceptibility to Coronary Artery Disease
por: Yari, Mohsen, et al.
Publicado: (2018)

Value of M2BP in predicting in‐stent restenosis in patients after coronary drug‐eluting stent implantation
por: Yang, Le, et al.
Publicado: (2022)

Long noncoding RNA ANRIL promotes the malignant progression of cholangiocarcinoma by epigenetically repressing ERRFI1 expression
por: Yu, Yang, et al.
Publicado: (2020)

Middle and Distal Common Carotid Artery Stenting: Long-Term Patency Rates and Risk Factors for In-Stent Restenosis
por: Vértes, Miklós, et al.
Publicado: (2020)

The Long Non-Coding RNA ANRIL in Cancers
por: Sanchez, Aymeric, et al.
Publicado: (2023)

The long noncoding RNA ANRIL acts as an oncogene and contributes to paclitaxel resistance of lung adenocarcinoma A549 cells
por: Xu, Ran, et al.
Publicado: (2017)

Long Noncoding RNA ANRIL Promotes Cervical Cancer Development by Acting as a Sponge of miR-186
por: Zhang, Jun-Jun, et al.
Publicado: (2018)

Diagnostic value of intraluminal stent enhancement in estimating coronary in-stent restenosis
por: Nogourani, Mehdi Karami, et al.
Publicado: (2020)

Prognostic value of post-procedural μQFR for drug-coated balloons in the treatment of in-stent restenosis
por: Liu, Lili, et al.
Publicado: (2023)

The long-term prognostic significance of high-sensitive C-reactive protein to in-stent restenosis
por: Zhu, Xinyi, et al.
Publicado: (2018)

Predictive value of neutrophil-to-lymphocyte ratio on drug eluting stent restenosis in patients with type 2 diabetes mellitus
por: Wang, Zhi-Chao, et al.
Publicado: (2020)

Prognostic Role of Fasting Remnant Cholesterol with In-Stent Restenosis After Drug-Eluting Stent Implantation
por: Luo, Yinhua, et al.
Publicado: (2022)

Plasma MicroRNAs as Potential Noninvasive Biomarkers for In-Stent Restenosis
por: He, Meijiao, et al.
Publicado: (2014)

Prognostic Significance of Long Non Coding RNA ANRIL and SNHG14 in Acute Myeloid Leukemia
por: Gamaleldin, Marwa A, et al.
Publicado: (2021)

Long noncoding RNA ANRIL as a novel biomarker of lymph node metastasis and prognosis in human cancer: a meta-analysis
por: Wang, Han, et al.
Publicado: (2017)

Long Noncoding RNA ANRIL: Lnc-ing Genetic Variation at the Chromosome 9p21 Locus to Molecular Mechanisms of Atherosclerosis
por: Holdt, Lesca M., et al.
Publicado: (2018)

Long noncoding RNA ANRIL could be transactivated by c-Myc and promote tumor progression of non-small-cell lung cancer
por: Lu, Yi, et al.
Publicado: (2016)

Intravascular Ultrasound-Guided Treatment for In-stent Restenosis Associated with Stent Fracture in Overlapped Drug-eluting Stents
por: Kim, Min Chul, et al.
Publicado: (2019)

Drug-eluting stent in-stent restenosis and re-restenosis: A hard time story
por: Dinesch, Violeta, et al.
Publicado: (2017)

Prognostic value of the long noncoding RNA HOTTIP in human cancers
por: Li, Wei, et al.
Publicado: (2017)

The Predictors of Target Lesion Revascularization and Rate of In-Stent Restenosis in the Second-Generation Drug-Eluting Stent Era
por: Zheng, Chengbin, et al.
Publicado: (2019)

The role of long non-coding RNA ANRIL in the development of atherosclerosis
por: Gareev, Ilgiz, et al.
Publicado: (2022)

Expression and clinical value of lncRNA MALAT1 and lncRNA ANRIL in glaucoma patients
por: Zheng, Miao, et al.
Publicado: (2020)

Viabahn for femoropopliteal in-stent restenosis
por: Al Shammeri, Owayed, et al.
Publicado: (2012)

Current Management of In-Stent Restenosis
por: Her, Ae-Young, et al.
Publicado: (2018)

Calcified in-stent restenosis in a venous stent
por: Schmidt, Jens-Ove, et al.
Publicado: (2015)

Hypersensitivity and in-stent restenosis in coronary stent materials
por: Hu, Wansong, et al.
Publicado: (2022)

Therapeutic Strategy for In-Stent Restenosis Based on the Restenosis Pattern After Drug-Eluting Stent Implantation
por: Kim, Ki-Hun, et al.
Publicado: (2009)

Response to drug-eluting stent in-stent restenosis and re-restenosis: A hard time story
Publicado: (2017)

Overexpression of long noncoding RNA ANRIL inhibits phenotypic switching of vascular smooth muscle cells to prevent atherosclerotic plaque development in vivo
por: Hu, Da-Jun, et al.
Publicado: (2020)

Compositional and functional properties of high-density lipoproteins in relation to coronary in-stent restenosis
por: Ganjali, Shiva, et al.
Publicado: (2021)

Long Noncoding RNA SNHG7 Is a Diagnostic and Prognostic Marker for Colon Adenocarcinoma
por: Jiang, Chengwei, et al.
Publicado: (2022)

Long Noncoding RNA Expression Signatures of Metastatic Nasopharyngeal Carcinoma and Their Prognostic Value
por: Zhang, Wei, et al.
Publicado: (2015)

Platelets in In-stent Restenosis: From Fundamental Role to Possible Prognostic Application
por: Haybar, Habib, et al.
Publicado: (2020)

Noncoding RNAs in Vascular Cell Biology and Restenosis
por: Efovi, Denis, et al.
Publicado: (2022)

Overlap stenting for in-stent restenosis after carotid artery stenting
por: Nishihori, Masahiro, et al.
Publicado: (2016)

Prognostic Value of High-Sensitivity C-Reactive Protein in In-Stent Restenosis: A Meta-Analysis of Clinical Trials
por: Yi, Ming, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_hkb9pltqvtginvtmno5fs2kfuc